Related Experiment Videos
Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy
M J Budoff1, D M Shavelle, D H Lamont
1Department of Medicine, Harbor-UCLA Medical Center, Torrance, California, USA. Budoff@Flash.net
Insights
Electron beam computed tomography (EBCT) accurately detects coronary calcification (CC) to distinguish between ischemic and nonischemic cardiomyopathy. This noninvasive imaging technique offers high sensitivity and specificity for determining heart failure etiology.
Area of Science:
- Cardiology
- Radiology
- Medical Imaging
Background:
- Differentiating the cause of cardiomyopathy (ischemic vs. nonischemic) is crucial for patient management and prognosis.
- Clinical assessment alone can be insufficient to determine the etiology of heart failure.
- Electron beam computed tomography (EBCT) offers noninvasive assessment of coronary artery calcification (CC), a marker for coronary artery disease (CAD).
Purpose of the Study:
- To evaluate the efficacy of EBCT in distinguishing between ischemic and nonischemic cardiomyopathy.
- To assess the correlation between EBCT-detected coronary calcification and the etiology of cardiomyopathy.
- To determine the diagnostic accuracy of EBCT for identifying coronary-induced heart failure.
Main Methods:
- A prospective, blinded study involving 125 patients with cardiomyopathy (ejection fraction <0.40) and known coronary anatomy.
- Patients underwent EBCT for coronary calcification (CC) evaluation within 3 months of coronary angiography.
- EBCT findings were correlated with established coronary anatomy to determine the etiology of cardiomyopathy.
Main Results:
- EBCT demonstrated high sensitivity (99%) in detecting CC in patients with ischemic cardiomyopathy (71/72 patients).
- Patients with nonischemic cardiomyopathy showed significantly lower CC scores (mean 17+/-51) compared to ischemic cases (mean 798+/-899).
- The overall accuracy of EBCT in differentiating the etiology of cardiomyopathy was 92%, with a specificity of 83% for excluding CAD using a CC score of 0.
Conclusions:
- EBCT accurately detects coronary calcification (CC) in patients with cardiomyopathy.
- This noninvasive imaging modality effectively distinguishes between cardiomyopathy caused by coronary artery disease (CAD) and nonischemic causes.
- EBCT provides a valuable tool for determining the etiology of left ventricular dysfunction.
Objectives:
This study was undertaken to evaluate the ability of electron beam computed tomography (EBCT) to distinguish ischemic from nonischemic causes of cardiomyopathy by evaluating heart failure patients for coronary calcification (CC).
Background:
The etiology of heart failure, whether coronary-induced or nonischemic, may be difficult to discern clinically. Differentiation of ischemic from nonischemic etiology is clinically important for both therapeutic and prognostic implications. With its ability to noninvasively discern and quantitate coronary artery calcification, EBCT correlates well with angiographic stenosis and thus may be useful in distinguishing ischemic and nonischemic cardiomyopathies.
Methods:
One hundred and twenty-five patients with cardiomyopathy (ejection fraction <0.40) and known coronary anatomy underwent EBCT coronary scanning to evaluate for CCs within 3 months of coronary angiography.
Results:
Of the 72 patients who were found to have ischemic cardiomyopathy, 71 patients had CC by EBCT (sensitivity 99%, p < 0.001), mean score 798+/-899. In comparison, among the 53 patients without significant coronary artery disease (CAD) (nonischemic cardiomyopathy), the mean score was significantly lower (17+/-51; p < 0.0001), and 44 patients had a CC score of 0 (no CC present). The specificity of EBCT to exclude CAD in patients with cardiomyopathy was 83%, using a threshold CC score of 0, and 92% for scores <80 (p < 0.001). Overall accuracy for determining the etiology of cardiomyopathy (differentiating ischemic from nonischemic) was 92% for this technique.
Conclusions:
This prospective, blinded study indicates that EBCT detected CC accurately and can noninvasively distinguish between cardiomyopathy because of CAD and nonischemic causes of left ventricular dysfunction.